Remove Cardiothoracic Remove Research Remove TAVR
article thumbnail

TAVR System Shows Durable Clinical Outcomes, Strong Valve Performance in Low-Risk Aortic Stenosis Patients

DAIC

Data shows, versus surgery, the Evolut transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years, strong valve performance and durable clinical outcomes. Evolut TAVR vs. 9.3% Evolut TAVR vs. 9.3% Reardon, M.D., Grubb, M.D., 1 Herrmann H.

TAVR 52
article thumbnail

Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes

DAIC

By 2021 almost half of patients younger than 60 years were receiving TAVR rather than SAVR. The research team followed these patients for a median time of 2.4 years after TAVR and 4.9 She added that her research group has expanded their analysis to include a multi-state registry for better comparison of the two procedures. “As

article thumbnail

STS Announces Late-breaker Research to Be Presented at the 2024 Annual Meeting

DAIC

milla1cf Mon, 01/29/2024 - 11:00 January 29, 2024 — The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at the 2024 Annual Meeting taking place January 27 - 29 in San Antonio. The findings underscore the escalating need for both aortic and non-aortic valve cardiac surgeries following TAVR.

Research 111
article thumbnail

New Late-breaking Data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-effectiveness Benefits of TAVR Platform

DAIC

A cost-effectiveness analysis demonstrates the positive economic value of transcatheter aortic valve replacement (TAVR) using Evolut TAVR compared to surgical aortic valve replacement (SAVR) for low-risk patients. The findings showed a strong economic benefit of Evolut TAVR for low-risk patients from a U.S.

TAVR 52
article thumbnail

New Legislation Speeds Progress on Patient Access to New Technologies

Society of Thoracic Surgeons - Technology

Bucshon and Schrier on this important bill which will not only have a measurable impact on clinical research, but also make a difference in cardiovascular clinicians’ efforts to transform cardiovascular care and improve heart health.” The ACC looks forward to working with Reps. Learn more at sts.org. For more, visit acc.org.

article thumbnail

New Study Finds Mechanical Valves Offer Superior Long-Term Survival for Aortic Valve Replacement Patients Aged 60 and Younger

Society of Thoracic Surgeons - Congenital

The decision between a bioprosthetic and mechanical valve is one of the most consequential for patients requiring aortic valve replacement, said Michael Bowdish, MD, lead author of the study and a cardiothoracic surgeon at Cedars-Sinai Medical Center in Los Angeles.

article thumbnail

Published Research

Society of Thoracic Surgeons - Research

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.